FabiFlu Favipiravir 200 mg Tablets, 1 X 34, Treatment: Covid-19
₹ 3,500/Box
Strength
200 mg
Packaging Size
1 X 34
Brand
fabiflu
Composition
Favipiravir 200 Mg
Treatment
Covid-19
Manufacturer
Glenmark Pharmaceuticals
Form
Tablet
Prescription/Non prescription
Prescription
Availability
In Stock
Fabiflu/Favipiravir- Doctor Prescription is Mandatory Having received the manufacturing and marketing approval from the Drugs Controller General of India (DCGI), drug firm Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 patients. The prescription-based drug will be available as a 200 mg
Exports To: United States Of America | Saudi Arabia | Australia | Oman | United Kingdom
Find products similar to FabiFlu Favipiravir 200 Mg Tablets, 1 X 34, Treatment: Covid-19
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
23-04-2019
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Sept 2015
GST
27ALQPT6557L1Z0
Import Export Code (IEC)
ALQPT*****
Exports to
United States Of America | Saudi Arabia | Australia | Oman | United Kingdom
Established in the year 2017 at Maharashtra, India, we “PUSHTI CARE EXIM” are Sole Proprietorship (Individual) based firm, involved as the Wholesale Trader of Pharmaceutical Injections, Pharmaceutical Medicine, Eye Drop, Pharmaceutical Capsule, Pharmaceutical Tablet and much more. All our products are getting widely acclaimed among the large clientele for their exclusive designs, superior quality, and reliability. Apart from this, our ability to maintain timelines as well as quality in the assortment, providing cost effective solutions and assurance to make timely shipment of the orders placed by customers have assisted us positioning our name in the list of top-notch companies of the industry.We only deal in export
